title: Necrobiotic xanthogranuloma associated with monoclonal gammopathy: successful treatment with lenalidomide and dexamethasone.
authors.affiliation: Department of Hematology-Oncology, Mayo Clinic, 4500 San Pablo Road, Jacksonville, FL, 32224, USA. brd.850@gmail.com.
authors.forename: Bhagirathbhai R
authors.initials: BR
authors.lastname: Dholaria
authors.affiliation: Department of Dermatology, Mayo Clinic, 4500 San Pablo Road, Jacksonville, FL, 32224, USA.
authors.forename: Mark
authors.initials: M
authors.lastname: Cappel
authors.affiliation: Department of Hematology-Oncology, Mayo Clinic, 4500 San Pablo Road, Jacksonville, FL, 32224, USA.
authors.forename: Vivek
authors.initials: V
authors.lastname: Roy
mesh_terms: D020533:Angiogenesis Inhibitors / Q000008:administration & dosage; D018931:Antineoplastic Agents, Hormonal / Q000008:administration & dosage; D003907:Dexamethasone / Q000008:administration & dosage*; D004359:Drug Therapy, Combination; D006801:Humans; D000077269:Lenalidomide; D008297:Male; D008875:Middle Aged; D058252:Necrobiotic Xanthogranuloma / Q000150:complications / Q000175:diagnosis / Q000188:drug therapy*; D010265:Paraproteinemias / Q000150:complications / Q000175:diagnosis / Q000188:drug therapy*; D013792:Thalidomide / Q000008:administration & dosage / Q000031:analogs & derivatives*; D016896:Treatment Outcome
chemical_list: D020533:Angiogenesis Inhibitors; D018931:Antineoplastic Agents, Hormonal; D013792:Thalidomide; D003907:Dexamethasone; D000077269:Lenalidomide